Intellipharmaceutics International Inc. filed its Annual on Jun 05, 2023 for the period ending Nov 30, 2022. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 CAD | -.--% | -11.11% | +6.67% |
1st Jan change | Capi. | |
---|---|---|
+6.67% | 1.94M | |
+42.54% | 739B | |
+32.34% | 598B | |
-6.09% | 353B | |
+17.27% | 318B | |
+3.26% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+5.83% | 164B |
- Stock Market
- Equities
- IPCI.H Stock
- News Intellipharmaceutics International Inc.
- Intellipharmaceutics International Inc. Auditor Raises 'Going Concern' Doubt